Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma
Clinical trial NCT01492088 · COMPLETED
Trial details
- NCT number
- NCT01492088
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-16
- Primary completion
- 2016-10-12
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.